Skip to main content
. 2022 Nov 30;13:1018027. doi: 10.3389/fneur.2022.1018027

Table 4.

Matrix of pairwise comparison among hypoglycemic drugs on ADCS-ADL scale score (shown as mean difference and 95% confidence intervals).

Placebo ITSN20 ITSN40
SUCRA (%) 99.8 50.1 0.1
Placebo 0 0.02 (0.01,0.03) 0.04 (0.03,0.05)
ITSN20 −0.02 (−0.03, −0.01) 0 0.02 (0.01,0.03)
ITSN40 −0.04 (−0.05, −0.03) −0.02 (−0.03, −0.01) 0

SUCRA, Surface under the cumulative ranking curve; ITSN20, Intranasal insulin 20IU; ITSN40, Intranasal insulin 40IU; ADCS-ADL, Alzheimer's Disease Cooperative Study-Activities of Daily Living Subscal.